Croda International Plc (LON:CRDA – Get Free Report) insider Steve Foots acquired 5 shares of the stock in a transaction dated Monday, May 11th. The stock was acquired at an average cost of GBX 2,850 per share, for a total transaction of £142.50.
Steve Foots also recently made the following trade(s):
- On Tuesday, May 5th, Steve Foots sold 73 shares of Croda International stock. The stock was sold at an average price of GBX 2,840, for a total transaction of £2,073.20.
- On Friday, April 10th, Steve Foots bought 5 shares of Croda International stock. The shares were acquired at an average cost of GBX 2,950 per share, with a total value of £147.50.
- On Tuesday, March 17th, Steve Foots sold 3,622 shares of Croda International stock. The stock was sold at an average price of GBX 2,606, for a total transaction of £94,389.32.
- On Tuesday, March 10th, Steve Foots purchased 6 shares of Croda International stock. The stock was acquired at an average price of GBX 2,798 per share, for a total transaction of £167.88.
Croda International Price Performance
Shares of LON CRDA traded down GBX 20 during trading on Tuesday, hitting GBX 2,802. The company had a trading volume of 1,193,682 shares, compared to its average volume of 4,409,664. Croda International Plc has a 52 week low of GBX 2,426.77 and a 52 week high of GBX 3,312. The business’s 50-day moving average is GBX 2,850.04 and its 200 day moving average is GBX 2,823.88. The company has a market cap of £3.90 billion, a P/E ratio of 63.11, a PEG ratio of 1.40 and a beta of 0.94. The company has a debt-to-equity ratio of 31.85, a quick ratio of 2.25 and a current ratio of 1.99.
Wall Street Analysts Forecast Growth
A number of equities analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft dropped their price target on Croda International from GBX 3,100 to GBX 3,000 and set a “hold” rating on the stock in a research note on Tuesday, March 24th. Morgan Stanley raised shares of Croda International to an “overweight” rating and upped their price objective for the company from GBX 3,280 to GBX 3,350 in a research note on Wednesday, March 25th. Finally, Jefferies Financial Group reiterated a “hold” rating and issued a GBX 3,000 target price on shares of Croda International in a report on Wednesday, April 22nd. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of GBX 3,140.
Croda International Company Profile
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
Featured Stories
- Five stocks we like better than Croda International
- MP Materials Is Quietly Building a Rare Earth Powerhouse
- AI Demand Fuels Strong Q1 Earnings for Constellation Energy
- Sony’s $4 Billion Bet on Rock & Roll Royalties
- Ubiquiti’s Uptrend Can Continue, But Don’t Rush to Buy It
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.
